L&K Biomed Ltd. (KOSDAQ:156100)
South Korea
· Delayed Price · Currency is KRW 7,440.00
-400.00 (-5.10%)
At close: Apr 28, 2026
L&K Biomed Revenue
In the year 2025, L&K Biomed had annual revenue of 38.92B KRW with 7.84% growth. L&K Biomed had revenue of 8.61B in the quarter ending December 31, 2025, a decrease of -14.11%.
Revenue
38.92B
Revenue Growth
+7.84%
P/S Ratio
4.27
Revenue / Employee
385.35M
Employees
101
Market Cap
166.29B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 38.92B | 2.83B | 7.84% |
| Dec 31, 2024 | 36.09B | 6.19B | 20.69% |
| Dec 31, 2023 | 29.90B | 10.14B | 51.28% |
| Dec 31, 2022 | 19.77B | 4.39B | 28.59% |
| Dec 31, 2021 | 15.37B | -3.98B | -20.58% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SELVAS Healthcare | 30.82B |
| Remed | 24.50B |
| Noul Co.,Ltd. | 5.12B |
| MEDIANA Co.,Ltd | 64.94B |
| Neofect | 16.05B |
| QuantaMatrix | 3.69B |
| Hironic | 32.09B |
| ASTERASYS Co.,Ltd | 37.94B |